MaxCyte CFO granted 375,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MAXCYTE, INC. Chief Financial Officer Parmeet Ahuja received a grant of employee stock options covering 375,000 shares of Common Stock. The options have an exercise price of $0.6762 per share and expire on March 29, 2036.
According to the vesting schedule, 25% of the shares underlying this option vest on March 30, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, contingent on continued service. Following this grant, Ahuja holds 375,000 stock options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 375,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Twenty-five percent (25%) of the shares underlying this option shall vest on March 30, 2027, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Key Figures
Key Terms
Employee Stock Option (right to buy) financial
vesting financial
exercise price financial
expiration date financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MXCT CFO Parmeet Ahuja receive in this Form 4 filing?
What is the exercise price of the new MXCT stock options?
How do the MXCT CFO’s 375,000 options vest over time?
When do the newly granted MXCT stock options expire?
How many MXCT stock options does the CFO hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.